ABOUT DANAHER LIFE SCIENCES
Every day, scientists around the world are dedicated to unraveling the mysteries of disease, discovering novel therapies and vaccines, and conducting crucial drug testing. At Danaher Life Sciences, a collection of businesses within Danaher Corporation, we play a pivotal role in facilitating these cutting-edge scientific endeavors. Our comprehensive capabilities go beyond research, enabling us to drive the development of innovative biopharmaceuticals, revolutionary cell and gene therapies, and other breakthrough treatments that propel patient health forward and enhance treatment outcomes.


FEATURED ARTICLES
-
mRNA analysis depends on methods that can separate broad size ranges. Learn how retention time can help estimate transcript length and complement capillary electrophoresis workflows.
-
Aggregation can compromise mAb quality at many stages of development. Learn why size exclusion chromatography is a trusted approach for detecting aggregates and supporting confident characterization.
-
Peptide mapping helps reveal AAV capsid protein identity, sequence coverage, and potential modification patterns, giving gene therapy teams a clearer view of viral protein quality across workflows.
-
ADC characterization does not have to be overwhelmed by complex intact MS profiles. Smart column selection can improve separation, clarify critical quality attributes, and make ADC analysis easier.
-
Glycan profiling starts with effective clean-up. See how comparable recovery across key labeled glycans and sialylated glycan groups can support confident analysis while helping labs manage costs.
-
DAR is a key quality attribute that shapes ADC potency, safety, stability, and developability. Learn why accurate measurement and control are essential as ADC pipelines expand and expectations rise.
-
SEC for monoclonal antibodies is not always as simple as choosing a column and running PBS. Secondary interactions can affect recovery, making thoughtful method development essential.
-
Read about how HPLC protein purification enables precise, reproducible isolation of target proteins from complex mixtures while preserving structure and activity—supporting high-purity workflows.
-
Effective protein purification starts with matching the method to the molecule and the application. Learn how scale, throughput, purity goals, and empirical optimization influence successful recovery.
-
Cancer mortality is declining, but the need for earlier action remains. Gain insight into how MCED and MRD are advancing cancer detection and surveillance, helping clinicians identify disease sooner.
-
New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.
-
Whole exome sequencing is accelerating genetic discovery. Learn how it enables biomarker detection, supports cancer research, and expands opportunities for scalable, future-ready genomic analysis.
-
Build stronger qPCR assays by delving into how to troubleshoot common issues, improve reproducibility, and confidently quantify gene expression across a wide range of experimental conditions.
-
Skip time-consuming extraction steps and achieve reliable qPCR results. Direct amplification methods help researchers detect respiratory pathogens more efficiently across saliva and nasal samples.
-
Skip extraction and move straight to amplification with a streamlined qPCR workflow. Achieve comparable performance across multiple targets while reducing costs and saving time.
-
Residual inhibitors in GI-derived DNA can hinder qPCR performance. An optimized approach improves inhibitor tolerance and enables earlier target detection, delivering more reliable amplification.
-
Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.
-
Learn how sequencing strategy, library prep, and data quality considerations shape outcomes in modern genomics. Clear insights help optimize workflows across a wide range of sequencing applications.
-
Bringing CRISPR therapies to market requires navigating complex global regulations. Learn how strategic planning, risk assessment, and manufacturing alignment can streamline development.
-
Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.
CONTACT INFORMATION
Danaher Life Sciences
500 Old Connecticut Path
Framingham, MA 01701
UNITED STATES